Marked radiographic response of a HER-2-overexpressing biliary cancer to trastuzumab
Steven SorscherWashington University School of Medicine, Department of Oncology, St Louis, MO, USAAbstract: Trastuzumab is a monoclonal antibody targeting HER-2. HER-2 overexpression has been described in gallbladder cancer and in cholangiocarcinoma. This report describes the first case of a patien...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2013-12-01
|
| Series: | Cancer Management and Research |
| Online Access: | http://www.dovepress.com/marked-radiographic-response-of-a-her-2-overexpressing-biliary-cancer--a15255 |